Wealth Enhancement Advisory Services, LLC Enanta Pharmaceuticals Inc Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 11,111 shares of ENTA stock, worth $80,332. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,111Holding current value
$80,332% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ENTA
# of Institutions
113Shares Held
18.8MCall Options Held
5.6KPut Options Held
13.9K-
Farallon Capital Management LLC San Francisco, CA2.12MShares$15.3 Million0.07% of portfolio
-
Krensavage Asset Management, LLC New York, NY2.12MShares$15.3 Million6.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.01MShares$14.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$13.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.35MShares$9.74 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $150M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...